Evidence map›Paper›PMID 36962785›Full record

ArticlePLOS global public health2022

Understanding barriers and facilitators to clinic attendance and medication adherence among adults with hypertensive urgency in Tanzania.

Godfrey A Kisigo, Onike C Mcharo, John L Robert, Robert N Peck, Radhika Sundararajan, Elialilia S Okello

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Godfrey A KisigoMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.ORCID https://orcid.org/0000-0001-6454-3969
Onike C McharoMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
John L RobertMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.ORCID https://orcid.org/0000-0003-2772-4941
Robert N PeckMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Radhika SundararajanCenter for Global Health, Weill Cornell Medicine, New York, New York, United States of America.
Elialilia S OkelloMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Cornell University · USMwanza Intervention Trials Unit · TZ

Funding

Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)D43TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, HEIMBURGER, DOUGLAS CORBETT · 2017 to 2021
$6.3M
HIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian CohortR01HL160332 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PECK, ROBERT N · 2021 to 2025
$2.7M
Post-Doctoral Fellowship Training in HIV Clinical InvestigationD43TW011826 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI Daniel W Fitzgerald, Saidi Kapiga · 2021 to 2026
$1.9M
FIC NIH HHS D43 TW009337FIC NIH HHS D43 TW011826NHLBI NIH HHS R01 HL160332
6 · The paper itself

Abstract

Hypertensive urgency is a major risk factor for cardiovascular events and premature deaths. Lack of medication adherence is associated with poor health outcomes among patients with hypertensive urgency in resource-limited settings. To inform the development of tailored interventions to improve health outcomes in this population, this study aimed at understanding facilitators and barriers to clinic attendance and medication adherence among Tanzanian adults with hypertensive urgency. We conducted in-depth interviews with 38 purposively selected participants from three groups: 1) patients with hypertension attending hypertension clinic, 2) patients with hypertension not attending hypertension clinic, and 3) clinic health workers. Interviews were conducted using a semi-structured guide which included open-ended questions with prompts to encourage detailed responses. In their narrative, patients and healthcare workers discussed 21 types of barriers/facilitators to clinic attendance and medication adherence: 12 common to both behaviors (traditional medicine, knowledge and awareness, stigma, social support, insurance, reminder cues, symptoms, self-efficacy, peer support, specialized care, social services, religious beliefs); 6 distinct to clinic attendance (transport, clinic location, appointment, patient-provider interaction, service fragmentation, quality of care); and 3 distinct to medication adherence (drug stock, side effects, medicine beliefs). The majority of identified barriers/facilitators overlap between clinic attendance and medication adherence. The identified barriers may be surmountable using tailored supportive intervention approaches, such as peer counselors, to help patients overcome social challenges of clinic attendance and medication adherence.

Identifiers

PMID36962785
PMCPMC10021323
OpenAlexW4292767170

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read26
identifiers read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.